Filing Details
- Accession Number:
- 0001415889-24-003207
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-09 17:50:28
- Reporting Period:
- 2024-02-07
- Accepted Time:
- 2024-02-09 17:50:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1775323 | Lupher, Jr. Mark L. | C/O Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City CA 94063 | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-02-07 | 130,000 | $1.35 | 130,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Shares of the Issuer's common stock were purchased in the Issuer's private placement of common stock pursuant to a Securities Purchase Agreement, dated February 5, 2024, by and among the Issuer and the other purchaser named therein. The shares of common stock acquired were purchased at a price per share of $1.35.
- The shares are held by a traditional IRA for the benefit of the Reporting Person.
Billionaire Hedge Funds
